Comparison of sequential versus combinatorial regimens in subcutaneous or orthotopic HNSCC mice revealed that CDK4/6i priming before anti‐PD‐1 enhances response durability by promoting CD8+ and CD4+ T cell infiltration and decreasing overall neutrophil abundance. Here, CDK4 is linked to head and neck squamous cell carcinoma.